We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Kallikrein 9 (KLK9) Antibodies|
|Epitope||AA 236-250, C-Term Alternatives|
|Conjugate||This Kallikrein 9 antibody is un-conjugated Alternatives|
Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-Kallikrein 9 AntibodyTarget Details Kallikrein 9 Application Details Handling Images
|Purpose||Rabbit IgG polyclonal antibody for Kallikrein-9(KLK9) detection. Tested with WB in Human.|
|Cross-Reactivity (Details)||No cross reactivity with other proteins.|
Rabbit IgG polyclonal antibody for Kallikrein-9(KLK9) detection. Tested with WB in Human.
Gene Name: kallikrein-related peptidase 9
Protein Name: Kallikrein-9
|Purification||Immunogen affinity purified.|
|Immunogen||A synthetic peptide corresponding to a sequence at the C-terminus of human Kallikrein 9(236-250aa SVCHYLDWIQEIMEN).|
|Plasmids, Primers & others|
Target Details Kallikrein 9Product Details anti-Kallikrein 9 Antibody Application Details Handling Images back to top
|Alternative Name||KLK9 (KLK9 Antibody Abstract)|
KLK9(kallikrein-related peptidase 9) also known as kallikrein 9 or KLK-L3, belongs to the kallikrein subgroup of serine proteases, which have diverse physiologic functions in many tissues. The KLK9 gene contains 5 coding exons and is mapped to 19q13.41. The KLK9 gene is regulated by steroid hormones in a human breast cancer cell line. Yousef et al.(2001) performed a quantitative analysis of KLK9 expression in ovarian cancer. The results indicated thatKLK9 is under steroid hormone regulation in ovarian and breast cancer cell lines. KLK9 is a potential independent favorable prognostic marker for early-stage, low-grade, optimally debulked ovarian cancer patients.
Synonyms: Kallikrein 8 antibody|Kallikrein 9 antibody|Kallikrein L3 antibody|Kallikrein Like 3 antibody|Kallikrein like protein 3 antibody|kallikrein related peptidase 9 antibody|Kallikrein-9 antibody|Kallikrein-like protein 3 antibody|Kallikrein8 antibody|Kallikrein9 antibody|KLK 8 antibody|KLK 9 antibody|KLK L3 antibody|KLK-L3 antibody|KLK8 antibody|KLK9 antibody|KLK9_HUMAN antibody|KLKL 3 antibody|KLKL3 antibody
Application DetailsProduct Details anti-Kallikrein 9 Antibody Target Details Kallikrein 9 Handling Images back to top
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Human
Notes: Tested Species: Species with positive results. Predicted Species: Species predicted to be fit for the product based on sequence similarities.
Other applications have not been tested. Optimal dilutions should be determined by end users.
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
|Restrictions||For Research Use only|
HandlingProduct Details anti-Kallikrein 9 Antibody Target Details Kallikrein 9 Application Details Images back to top
|Reconstitution||Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.|
|Buffer||Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.|
|Preservative||Thimerosal (Merthiolate), Sodium azide|
|Precaution of Use||This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
|Expiry Date||12 months|
ImagesProduct Details anti-Kallikrein 9 Antibody Target Details Kallikrein 9 Application Details Handling back to top